Plummeting Sun Pharma shares by 10% this year; Citigroup's top pharmaceutical choice with anticipated profits exceeding Rs 500
Sun Pharma, the Indian pharmaceutical giant, is making waves in the global market with its pipeline of innovative drugs. Here's a breakdown of the analyst forecasts for three of its drugs - Ilumya, Leqselvi, and Unlocxyt - in the US stock market up to 2030.
Unlocxyt, a drug positioned as an alternative for immunocompromised patients, is expected to be sold primarily in the US stock market by 2030. Analysts predict that this drug will achieve sales of USD 500 million by that year.
Leqselvi, another Sun Pharma drug, is already covered in the US stock market and is forecasted to reach sales of USD 600 million by 2030. Ilumya, Sun Pharma's psoriasis drug, is expected to generate revenues of nearly USD 1.4 billion by FY30E. In the US stock market alone, Ilumya clocked sales of about USD 550 million in FY25.
However, there are no publicly available specific analyst forecasts detailing annual US stock market sales projections for Ilumya, Leqselvi, and Unlocxyt up to 2030.
Meanwhile, the stock markets are focusing on other news, such as 'I am very close to the Prime Minister of India': Donald Trump, and the GK Energy IPO GMP subscription beginning today.
Citi has issued a brokerage report on Sun Pharma stock, increasing the price target for Sun Pharma shares for five reasons. The record date for NSDL dividend 2025 is today, and the credit date for the dividend will be after Diwali.
Elsewhere, TCS and Vodafone Idea have inked a 5-year deal for an unspecified reason, and the government's big plan for Indian Railways includes 1000 Amrit Bharat Express and up to 200 Vande Bharat Sleeper trains.
In other corporate news, Samvardhana Motherson's share price target has been hiked with a Sell rating by Citi, and MobiKwik has frozen 2000 merchant accounts due to huge losses. IREAD shares are in focus after a loan sanction of Rs 1134 crore for a solar cell.
Read also:
- Shaping India's Economic Progression: Readying the Financial System for Tomorrow
- Conflict between Ben & Jerry's co-founder and Unilever over Gaza issues leads to resignation of co-founder
- Two farmers in Zambia take legal action against two firms with Chinese connections, alleging an ecological disaster caused by their operations.
- Deepening EU-India relations despite apprehensions regarding Moscow connections
